-
1.发明申请NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS 有权UBIQUITIN特异性蛋白质的新型选择性抑制剂7，其药物组合物及其治疗应用公开(公告)号：US20150072973A1
公开(公告)日：2015-03-12
申请号：US14488601
申请日：2014-09-17
Applicant: HYBRIGENICS SA
Inventor： Roman Lopez , Frederic Colland
IPC: C07D401/12 , A61K31/496 , A61K45/06 , A61K31/55 , C07D219/04 , A61K31/435
CPC classification number: C07D401/12 , A61K31/435 , A61K31/496 , A61K31/55 , A61K45/06 , C07D219/04 , C07D219/06 , C07D401/14 , Y02A50/463 , Y02A50/465
Abstract: The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use.
Abstract translation: 本发明涉及泛素特异性蛋白酶的新选择性抑制剂的发现，其制备方法及其治疗用途。
-
2.发明授权Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications 有权泛素特异性蛋白酶7的选择性抑制剂，其药物组合物及其治疗应用公开(公告)号：US09328093B2
公开(公告)日：2016-05-03
申请号：US14488601
申请日：2014-09-17
Applicant: HYBRIGENICS SA
Inventor： Roman Lopez , Frederic Colland
IPC: A61K31/44 , C07D401/12 , C07D219/04 , C07D219/06 , C07D401/14 , A61K31/435 , A61K31/496 , A61K31/55 , A61K45/06
CPC classification number: C07D401/12 , A61K31/435 , A61K31/496 , A61K31/55 , A61K45/06 , C07D219/04 , C07D219/06 , C07D401/14 , Y02A50/463 , Y02A50/465
Abstract: The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use.
Abstract translation: 本发明涉及泛素特异性蛋白酶的新选择性抑制剂的发现，其制备方法及其治疗用途。
-
Search Results
2
records
(took 0.033 seconds)
